drugset / Trial / NCT03809702
Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia
Phase 4
Completed
82 enrolled
B.P. Koirala Institute of Health Sciences
University Grants Commission · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
All eligible Herpes Zoster patients will be randomized into two groups. Group 1 will be the treatment group receiving Pregabalin 75 mg twice daily for 4 weeks in addition to other routine treatment. Whereas, group 2 will be the control group receiving all routine treatment similar to group 1 except Pregabalin. Instead control group will receive Placebo.
Timeline
- Start
- 2018-07-15
- Primary completion
- 2019-09-20
- Completion
- 2019-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregabalin | Small molecule | 75 mg | Oral |